Recherche
Enseignement
Solutions
S'identifier
FR
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Osteoncology and Rare Tumors Center,
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST),
Osteoncology and Rare Tumors Center, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST)
Giacomo Miserocchi has not added Biography.
If you are Giacomo Miserocchi and would like to personalize this page please email our Author Liaison for assistance.
Development of a Patient-Derived Xenograft (PDX) of Breast Cancer Bone Metastasis in a Zebrafish Model.
International journal of molecular sciences Aug, 2016 | Pubmed ID: 27556456
Recombinant granulocyte colony-stimulating factor (rG-CSF) in the management of neutropenia induced by anthracyclines and ifosfamide in patients with soft tissue sarcomas (NEUSAR).
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer Jan, 2017 | Pubmed ID: 27568305
Current classification, treatment options, and new perspectives in the management of adipocytic sarcomas.
OncoTargets and therapy , 2016 | Pubmed ID: 27785071
The Effect of Everolimus in an In Vitro Model of Triple Negative Breast Cancer and Osteoclasts.
International journal of molecular sciences Nov, 2016 | Pubmed ID: 27809291
Innovative approaches to establish and characterize primary cultures: an ex vivo 3D system and the zebrafish model.
Biology open Feb, 2017 | Pubmed ID: 27895047
Activity of Eribulin in a Primary Culture of Well-Differentiated/Dedifferentiated Adipocytic Sarcoma.
Molecules (Basel, Switzerland) Dec, 2016 | Pubmed ID: 27918490
Vitamin D receptor polymorphisms or serum levels as key drivers of breast cancer development? The question of the vitamin D pathway.
Oncotarget Feb, 2017 | Pubmed ID: 28061456
CORRECTION: Innovative approaches to establish and characterize primary cultures: an ex vivo 3D system and the zebrafish model.
Biology open Feb, 2017 | Pubmed ID: 28202474
Update on the role of trabectedin in the treatment of intractable soft tissue sarcomas.
OncoTargets and therapy , 2017 | Pubmed ID: 28260930
Tumor-Stroma Crosstalk in Bone Tissue: The Osteoclastogenic Potential of a Breast Cancer Cell Line in a Co-Culture System and the Role of EGFR Inhibition.
International journal of molecular sciences 07, 2017 | Pubmed ID: 28758931
Management and potentialities of primary cancer cultures in preclinical and translational studies.
Journal of translational medicine Nov, 2017 | Pubmed ID: 29116016
Primary leiomyosarcoma of the bone: a case report and a review of the literature.
Medicine Nov, 2017 | Pubmed ID: 29137065
Osteoblastic bone metastases from neuroendocrine tumor (NET) of unknown origin detected by 18fluorocholine PET/CT and its comparison with 68gallium-DOTATOC PET/CT: Case report and review of the literature.
Medicine Nov, 2017 | Pubmed ID: 29145267
Primary Culture of Undifferentiated Pleomorphic Sarcoma: Molecular Characterization and Response to Anticancer Agents.
International journal of molecular sciences Dec, 2017 | Pubmed ID: 29292724
Myxofibrosarcoma primary cultures: molecular and pharmacological profile.
Therapeutic advances in medical oncology Dec, 2017 | Pubmed ID: 29449896
IRCCS
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy
Laura Mercatali1,
Chiara Spadazzi1,
Giacomo Miserocchi1,
Chiara Liverani1,
Alessandro De Vita1,
Alberto Bongiovanni1,
Federica Recine1,
Dino Amadori1,
Toni Ibrahim1
1Osteoncology and Rare Tumors Center, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), IRCCS
Federica Pieri2,
Davide Cavaliere3,
Valentina Fausti1,
1Osteoncology and Rare Tumors Center, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS,
2Pathology Unit, Morgagni-Pierantoni Hospital,
3Unit of Surgery and Advanced Oncologic Therapies, Morgagni-Pierantoni Hospital
Patrizia Serra2,
Giorgia Marisi3,
Akwilina Pangan4,
Nestory Masalu4,
Toni Ibrahim1,
Dino Amadori1
1Osteoncology and Rare Tumors Center, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy,
2Unit of Biostatistics and Clinical Trials, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy,
3Biosciences Laboratory, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy,
4Department of Oncology, Bugando Medical Center, Mwanza, Tanzania
Confidentialité
Conditions d'utilisation
Politiques
Contactez-nous
RECOMMANDER À LA BIBLIOTHÈQUE
NEWSLETTERS JoVE
JoVE Journal
Collections de méthodes
JoVE Encyclopedia of Experiments
Archives
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Centre de ressources universitaires
Auteurs
Bibliothécaires
Accès
À PROPOS DE JoVE
Copyright © 2024 MyJoVE Corporation. Tous droits réservés.